Monitor Q3 and Q4 2026 filings for early adoption metrics of HitRix and any acceleration in carrier onboarding. The flat revenue guidance suggests near-term headwinds; a material inflection in 2027 depends on execution of the new platform and stabilization program.
Price Chart
Executive Summary
Health In Tech launched HitRix, an AI-powered platform for the large-group self-funded health insurance market, and updated its full-year 2026 revenue guidance to approximately $33 million, roughly flat year-over-year. The Q2 2026 EPS of -$0.03 beat consensus of -$0.04 by 14.3%, but the flat revenue outlook signals a growth pause as strategic initiatives ramp into 2027.
Key Financial Metrics
Key Facts
- Launched HitRix, an AI-powered platform for large-group self-funded health insurance submissions and quoting.
- Updated full-year 2026 revenue guidance to approximately $33 million, roughly in line with 2025 revenue.
- Q2 2026 EPS of -$0.03 beat consensus of -$0.04 (14.3% beat).
- Partner ecosystem grew 19.9% YoY to 933 partners as of June 30, 2026.
- Company expects HitRix, Three-Year Rate Stabilization Program, and expanded carrier capacity to contribute meaningfully in 2027 and beyond.
Financial Impact
Revenue guidance of ~$33M for FY2026, flat YoY; Q2 EPS beat by $0.01 vs consensus.
Risk Factors
- Flat revenue guidance for FY2026 indicates delayed growth from strategic initiatives.
- HitRix adoption and carrier capacity expansion may not materialize as expected.
- Competition from other insurtech platforms and traditional brokers could limit market share gains.
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302894826 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 3d ago | 3 | $0.5753 | awaiting T+60 | — | $0.5005 (−13.00%) |
Oct 16, 2026 9d ago | 8-K | $0.6350 | awaiting T+60 | — | $0.5005 (+21.18%) |
Oct 16, 2026 10d ago | EFFECT | $0.6520 | awaiting T+60 | — | $0.5005 (+23.24%) |
Oct 13, 2026 13d ago | DEF 14A | $0.6780 | awaiting T+60 | — | $0.5005 (+26.18%) |
Oct 9, 2026 16d ago | S-3/A | $0.7200 | awaiting T+60 | — | $0.5005 (+30.49%) |
Sep 30, 2026 25d ago | Press Release | $0.7380 | awaiting T+60 | — | $0.5005 (−32.18%) |
Sep 29, 2026 27d ago | SC 13G | $0.8525 | awaiting T+60 | — | $0.5005 (−41.29%) |
Sep 4, 2026 7w ago | S-3 | $0.9801 | awaiting T+60 | — | $0.5005 (+48.93%) |
Aug 13, 2026 10w ago | Press Release | $1.01 | awaiting T+60 | — | $0.5005 (+50.20%) |
Jun 26, 2026 17w ago | S-3/A | $1.01 $0.8466 | ▲ +16.18% | ▲ +20.56% | $0.5005 (+50.45%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers